Earnings Call · Q4 FY2021·2022-01-26

Q4 21EPS -7.27%·Rev n/aQ3 21EPS +1.89%·Rev n/aQ2 21EPS +16.36%·Rev n/aQ1 21EPS +14.89%·Rev n/a⚠ consensus missing

Edwards Lifesciences Corp EW

Mark Wilterding — Vice President, Investor Relations

Mike Mussallem — Chairman and Chief Executive Officer

Scott Ullem — Chief Financial Officer

−6.1%1d on move date−5.6% vs SPY3d+0.5%5d+3.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EW calls or request research access.

More EW calls Browse calls Request research access